Fabien Vincent

3.8k total citations · 2 hit papers
34 papers, 1.9k citations indexed

About

Fabien Vincent is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, Fabien Vincent has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Pharmacology. Recurrent topics in Fabien Vincent's work include Ion Channels and Receptors (4 papers), Phytochemicals and Antioxidant Activities (3 papers) and Cancer therapeutics and mechanisms (3 papers). Fabien Vincent is often cited by papers focused on Ion Channels and Receptors (4 papers), Phytochemicals and Antioxidant Activities (3 papers) and Cancer therapeutics and mechanisms (3 papers). Fabien Vincent collaborates with scholars based in United States, Switzerland and France. Fabien Vincent's co-authors include Marco Prunotto, Jonathan A. Lee, Jörg Eder, John G. Moffat, Kavita Shah, Matthew A. J. Duncton, Yolanda de Pablo, Mark Mercola, Monica Schenone and Arsenio Nueda and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Fabien Vincent

32 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Opportunities and challenges in phenotypic drug discovery: an industry perspective

2017 571 citations John G. Moffat, Fabien Vincent et al. Nature Reviews Drug Discovery profile →
Phenotypic drug discovery: recent successes, lessons learned and new directions

2022 165 citations Fabien Vincent, Arsenio Nueda et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fabien Vincent United States	18	1.1k	267	256	227	203	34	1.9k
Peter Chase United States	24	1.2k 1.1×	248 0.9×	65 0.3×	151 0.7×	280 1.4×	68	2.0k
Karl A. Walter United States	20	1.1k 1.0×	222 0.8×	212 0.8×	348 1.5×	139 0.7×	34	1.8k
S. Adrian Saldanha United States	22	1.5k 1.4×	186 0.7×	68 0.3×	142 0.6×	221 1.1×	32	2.2k
Gaétan Guillemette Canada	29	1.7k 1.6×	166 0.6×	112 0.4×	188 0.8×	260 1.3×	102	2.3k
Hongyu Zhao United States	23	1.1k 1.0×	159 0.6×	320 1.3×	130 0.6×	99 0.5×	70	2.1k
Usha Warrior United States	21	672 0.6×	84 0.3×	70 0.3×	69 0.3×	53 0.3×	44	1.2k
Noam Nativ Israel	10	1.4k 1.3×	241 0.9×	133 0.5×	110 0.5×	61 0.3×	11	2.3k
Julie A. Zorn United States	16	947 0.9×	80 0.3×	81 0.3×	78 0.3×	90 0.4×	21	1.5k
HaJeung Park United States	27	1.7k 1.6×	129 0.5×	32 0.1×	111 0.5×	157 0.8×	68	2.4k
Andreas Kreusch United States	19	1.4k 1.3×	51 0.2×	85 0.3×	85 0.4×	69 0.3×	23	1.9k

Countries citing papers authored by Fabien Vincent

Since Specialization

Citations

This map shows the geographic impact of Fabien Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Vincent more than expected).

Fields of papers citing papers by Fabien Vincent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabien Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Vincent. The network helps show where Fabien Vincent may publish in the future.

Co-authorship network of co-authors of Fabien Vincent

This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Vincent. A scholar is included among the top collaborators of Fabien Vincent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Vincent. Fabien Vincent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vincent, Fabien & Davide Gianni. (2025). The limitations of small molecule and genetic screening in phenotypic drug discovery. Cell chemical biology. 32(11). 1310–1320.

Farley, Kathleen A., Ye Che, Ricardo Lira, et al.. (2024). Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar Couplings. ACS Medicinal Chemistry Letters. 15(11). 2060–2066.

Vincent, Fabien, Arsenio Nueda, Jonathan Lee, et al.. (2022). Phenotypic drug discovery: recent successes, lessons learned and new directions. Nature Reviews Drug Discovery. 21(12). 899–914. 165 indexed citations breakdown →

Vincent, Fabien, et al.. (2022). Publisher Correction: Phenotypic drug discovery: recent successes, lessons learned and new directions. Nature Reviews Drug Discovery. 21(7). 541–541. 6 indexed citations

Thorarensen, Atli, Paul Balbo, Mary Ellen Banker, et al.. (2020). The advantages of describing covalent inhibitor in vitro potencies by IC50 at a fixed time point. IC50 determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimization. Bioorganic & Medicinal Chemistry. 29. 115865–115865. 41 indexed citations

Vincent, Fabien, Paula M. Loria, Andrea D. Weston, et al.. (2020). Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies. Cell chemical biology. 27(11). 1332–1346. 29 indexed citations

Dresselhaus, Erica C., James M. Duerr, Fabien Vincent, et al.. (2018). Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion. PLoS ONE. 13(3). e0194661–e0194661. 16 indexed citations

Moffat, John G., Fabien Vincent, Jonathan A. Lee, Jörg Eder, & Marco Prunotto. (2017). Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nature Reviews Drug Discovery. 16(8). 531–543. 571 indexed citations breakdown →

Nguyen, Margaret, Donogh J. R. O’Mahony, Qingling Zhang, et al.. (2015). Identification of orally-bioavailable antagonists of the TRPV4 ion-channel. Bioorganic & Medicinal Chemistry Letters. 25(18). 4011–4015. 29 indexed citations

10.

Engle, Sandra J. & Fabien Vincent. (2013). Small Molecule Screening in Human Induced Pluripotent Stem Cell-derived Terminal Cell Types. Journal of Biological Chemistry. 289(8). 4562–4570. 36 indexed citations

11.

Vincent, Fabien, Yolanda de Pablo, Soumitra Ghosh, et al.. (2011). Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Molecular Biology of the Cell. 22(9). 1452–1462. 65 indexed citations

12.

Vincent, Fabien & Matthew A. J. Duncton. (2011). TRPV4 Agonists and Antagonists. Current Topics in Medicinal Chemistry. 11(17). 2216–2226. 118 indexed citations

13.

Vincent, Fabien, Margaret Nguyen, Daniel Emerling, Michael Kelly, & Matthew A. J. Duncton. (2009). Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): Identification of phenmedipham and amperozide as FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6793–6796. 8 indexed citations

14.

Sun, Kai-Hui, et al.. (2008). Novel Genetic Tools Reveal Cdk5's Major Role in Golgi Fragmentation in Alzheimer's Disease. Molecular Biology of the Cell. 19(7). 3052–3069. 87 indexed citations

15.

Pablo, Yolanda de, et al.. (2008). Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. Journal of Neurochemistry. 107(1). 265–278. 106 indexed citations

16.

Vincent, Fabien, et al.. (2007). Engineering Unnatural Nucleotide Specificity to Probe G Protein Signaling. Chemistry & Biology. 14(9). 1007–1018. 4 indexed citations

17.

Shah, Kavita & Fabien Vincent. (2005). Divergent Roles of c-Src in Controlling Platelet-derived Growth Factor-dependent Signaling in Fibroblasts. Molecular Biology of the Cell. 16(11). 5418–5432. 40 indexed citations

18.

Siwicki, Andrzej K., John C. Fuller, Steven Nissen, et al.. (2004). Effect of HMB (β-Hydroxy-β-Methylbutyrate) on in vitro Proliferative Responses of Sheatfish (Silurus glanis) and Catfish (Ictalurus melas) Lymphocytes Stimulated by Mitogens. Acta Veterinaria Brno. 73(1). 119–122. 12 indexed citations

19.

Legrand, Pierre, Stéphanie Bibert, Michel Jaquinod, et al.. (2001). Self-assembly of the Vascular Endothelial Cadherin Ectodomain in a Ca2+-dependent Hexameric Structure. Journal of Biological Chemistry. 276(5). 3581–3588. 26 indexed citations

20.

Steinmetz, Armin, et al.. (1990). Endotoxin Size in Hemodialysis Solutions: Modifications in Presence of Concentrated Salt Solutions and Bacterial Products. Advances in experimental medicine and biology. 256. 685–689. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact